The reaction of resorcinol with ethylacetoacetate yielded the 7-hydroxy-4-methyl coumarin (1), which on treatment with benzidine gives 1-(4'-aminobiphenyl-4-yl)-7-hydroxy-4-methyl-1H-quinolin-2-one (2). 1-{4'-[(Substituted benzylidene)-amino]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (3a-j) were obtained by reacting 1-(4'-amino-biphenyl-4-yl)-7-hydroxy-4-methyl-1H-quinolin-2-one (2) with different substituted aromatic aldehydes in presence of glacial acetic acid by microwave irradiation. The compound 1-{4'-[(substituted benzylidene)-amino]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (3a-j) on cyclization with chloro acetyl chloride in presence of triethylamine as catalyst under microwave irradiation furnished 1-{4'-[3-chloro-2-(substituted phenyl)-4-oxoazetidin-1-yl]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (4a-j). Purity of synthesized compounds was checked by TLC and the structures were elucidated by their IR, 1 H NMR, Mass and elemental analysis data. The synthesized compounds were screened for anticonvulsant activity.
Introduction
The derivatives of quinolinone have been known to possess various biological activities such as antitumour, antimalarial, antiplatelet, antidepressant, anticonvulsant, antiulcer, neuroleptic, cardiac stimulant, antiviral, antiasthmatic and anti-inflammatory activities 1 . Schiff base, a versatile lead molecule for potential bioactive agents and its derivatives have been reported to possess antibacterial, antifungal, antitumour, antimycobacterial and herbicidal activity 2, 3 . Azetidinone derivatives are also reported to have powerful antimicrobial, anti-inflammatory, anticonvulsant, carbonic anhydrase inhibitor, local anaesthetic, anthelmentic, hypoglycemic antitubercular activity, antiviral and hypolipidemic activity 4, 5 . On consideration of the above observations, it was worthwhile to synthesize some new 1-{4'-[(substituted benzylidene)-amino]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (3a-j) and 1-{4'-[3-chloro-2-(substituted phenyl)-4-oxo-azetidin-1-yl]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (4a-j) by using microwave and to screen them for their anticonvulsant activity.
Experimental
The melting points of synthesized compounds were determined by open capillary tubes using paraffin bath and are uncorrected. The purity was checked by TLC on silica gel G plates using benzene-methanol as developer detected by iodine vapors. The IR spectra were recorded on a JASCO FT-IR 4100 spectrophotometer, using KBr powder technique.
1 H NMR spectra were recorded on a Varian-NMR-mercury 300 MHz spectrophotometer in DMSO using TMS as an internal standard. Mass spectra were recorded on LC-MS/MS, API-4000 using Electrospray ionization (ESI) as a source. Microwave irradiations were carried out on CATA's Scientific Microwave Synthesis System-700 W, 2450 MHz domestic microwave oven. All solvents were dried, deoxygenated and redistilled before use.
7-Hydroxy-4-methyl coumarin (1) was synthesized according to reported procedure 6 . Yield: 81.96%, m.p. 184-186 °C.
1-(4'-Amino-biphenyl-4-yl)-7-hydroxy-4-methyl-1H-quinolin-2-one (2)
A mixture of 7-hydroxy-4-methyl coumarin (1) (1.76 g, 0.01 mole) and benzidine (1.84 g, 0.01 mole) in anhydrous pyridine (50 mL) was heated under reflux for five hours under anhydrous conditions. Subsequently, the reaction mixture was poured into ice (90 mL H 2 O + 10 mL HCL). A solid separated out which was filtered off and washed successively with water and purified by recrystallization from methanol.
Yield 
General procedure

1-{4'-[(Substitutedbenzylidene)-amino]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (3a-j)
To a mixture of 1-(4'-amino-biphenyl-4-yl)-7-hydroxy-4-methyl-1H-quinolin-2-one (2), (0.01 mole) in methanol (20 mL), substituted aromatic aldehydes (0.015 mole), glacial acetic acid (1 mL) were added and the reaction mixture was irradiated with microwaves at power level 8 (490 W) for about 5-10 minutes inside the microwave oven. Reaction was monitored by TLC after completion the reaction mixture was allowed to cool and poured over crushed ice. 
1-{4'-[3-chloro-2-(substituted phenyl)-4-oxo-azetidin-1-yl]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (4a-j)
A mixture of 1-{4'-[(substituted benzylidene)-amino]-biphenyl-4-yl}-7-hydroxy-4-methyl-1H-quinolin-2-one (3a-j) (0.01 mole) in DMF and chloroacetyl chloride (0.01 mole) with a catalytic amount of triethylamine (1 mL) were put in flask and irradiated under microwave for 5-25 minutes at power level 8 (490 W). Reaction was monitored by TLC after completion of reaction; it was then diluted with ice-cold water. The separated solid was filtered, dried and recrystallized from DMSO. 
Anticonvulsant activity
The experimental protocol was approved by the Institutional Animal Ethical Committee (IAEC) and was conducted according to the guidelines for use and care of experimental animals. Adult, healthy, overnight fasted, male albino mice, weighing between 20-25 g were used. They were housed under standard environmental conditions of temperature (24±2 °C), relative humidity of 30-70% and 12 h light/dark cycle as per CPCSEA guidelines. All animals had free access to water and standard pelletized laboratory animal diet ad libitum. The animals were divided into different groups with each group consisting of six animals. After 30 minutes of oral administration of test compounds, animals were stimulated through corneal electrodes with 50 mA current at a pulse of 60 Hz alternating current for 0.2 sec. The abolition of hind limb tonic extensor spasm was recorded as a measure of anticonvulsant activity. The above procedure was repeated after 60, 90 and 120 minutes of administration.
Statistical analysis
Data obtained from pharmacological experiments are expressed as mean ± S.E.M. At the end of experiment, test groups were compared with control and were tested for its significance using ANOVA followed by Dunnett's test. Values of P < 0.05 or lower were regarded as significant. The result of anticonvulsant activity of all the synthesized compounds is presented below.
Results and Discussion
After 30 minutes, compound 3b, 3c, 3j and 4h showed better activity, at 60 minutes interval compound 3a, 3c and 4a were found to show better activity, at 90 minutes, compound 3j, 4a and 4c exhibited better activity, whereas at 120 minutes, compound 3j, 4a and 4d displayed better activity. Thus, amongst all the synthesized compounds, compound 3j and 4a were found to be the most active candidates, compound 3c also exhibited good activity at 30 and 60 minutes, whereas the remaining compounds exhibited moderate activity. 
Conclusion
From the anticonvulsant data of the synthesized compounds, we can conclude that the compounds 3j and 4a have exhibited excellent anticonvulsant activity in MES model and hold promise as anticonvulsant agents after further development.
